Engrail Therapeutics
Latest round
- Series B
Last raised
- Mar 2024
Total raised
- $189M
Investors
- 10
About Engrail Therapeutics
Founded in 2019 by Stephen Cunningham and Vikram Sudarsan, and based in California, US, Engrail Therapeutics, Inc. is a pharmaceutical company that focuses on the research and development of medicines to treat patients suffering from neurological disorders and diseases. In March 2024, Engrail Therapeutics, Inc. The firm’s partners include Pivotal Life Sciences, Forbion, Rivervest, Norwest, etc. The firm develops precision-targeted therapies for neuropsychiatric and neurologic disorders. The company's approach leverages advanced chemistry and pharmacology to create treatments that maximize efficacy while minimizing side effects. Their lead compound, ENX-102, targets GABAA receptors for generalized anxiety disorder, enhancing neurotransmission. Additionally, the firm offers ENX-104 and ENX-105, compounds targeting dopamine D2/D3 receptors to address depression symptoms, including anhedonia. Moreover, the firm also develops ENX-103, a small molecule designed to correct copper transport defects in Menkes disease, facilitating proper copper distribution in the body.
Who invested in Engrail Therapeutics
10 investors across 2 rounds
See all investors in Engrail Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Engrail Therapeutics
Who invested in Engrail Therapeutics?
Engrail Therapeutics has 10 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Engrail Therapeutics raised?
Engrail Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Engrail Therapeutics last raise money?
Engrail Therapeutics's most recent round on record is a Series B, in Mar 2024.
What does Engrail Therapeutics do?
Founded in 2019 by Stephen Cunningham and Vikram Sudarsan, and based in California, US, Engrail Therapeutics, Inc.
Where is Engrail Therapeutics headquartered?
Engrail Therapeutics is headquartered in San Diego, US.
Which VCs invest in companies like Engrail Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Engrail Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Engrail Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.